Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
BioXcel Therapeutics, Inc. (BTAI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/10/2023 SC 13G/A FIL Ltd reports a 9.2% stake in BIOXCEL THERAPEUTICS INC
10/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioXcel Therapeutics Reports Positive Overall Survival Results from Single-Arm, Open-Label Phase 2 Trial of BXCL701 in Patients with Small Cell Neuroendocrine Prostate Cancer",
"Astria Therapeutics October 2023 1 Exhibit 99.2 Cautionary Note Regarding Forward Looking Statements and Disclaimer This"
10/04/2023 8-K Regulation FD Disclosure  Interactive Data
09/28/2023 SC 13D BioXcel LLC reports a 32.5% stake in BioXcel Therapeutics, Inc.
08/22/2023 8-K Other Events  Interactive Data
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization"
06/30/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/29/2023 8-K Other Events  Interactive Data
05/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/16/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 8-K Quarterly results
Docs: "BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights"
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/20/2023 8-K Quarterly results
04/04/2023 SC 13G/A BioXcel Holdings, Inc. reports a 30.3% stake in BioXcel Therapeutics, Inc.
03/17/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/16/2023 8-K Other Events  Interactive Data
03/15/2023 8-K Other Events  Interactive Data
03/09/2023 8-K Quarterly results
Docs: "BioXcel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights"
02/21/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended . Forward-looking statements in this presentation include but are not limited to: statements regarding BioXcel Therapeutics’ expected timing of, and data results from, trials and clinical studies involving its product candidates, in particular BXCL701; planned discussions with regulators and potential registrational trials; strategic options for OnkosXcel; and potential market size and opportunity for product cand..."
02/13/2023 8-K Quarterly results
02/09/2023 SC 13G/A BlackRock Inc. reports a 4.7% stake in BIOXCEL THERAPEUTICS INC
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in BIOXCEL THERAPEUTICS INC
02/03/2023 SC 13G BlackRock Inc. reports a 5.2% stake in BIOXCEL THERAPEUTICS INC
02/02/2023 SC 13G ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.5% stake in BioXcel Therapeutics, Inc.
11/30/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
09/12/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "® BioXcel Therapeutics | 555 Long Wharf Drive, 12th Floor | New Haven, CT 06511 | www.bioxceltherapeutics.com September 2022 AI-Driven Drug Development in Neuroscience and Immuno-oncology NASDAQ: BTAI"
08/19/2022 8-K Quarterly results
08/16/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy